News Headlines

Display #
Merck & Co. Plans to File NDA for HIV Treatment Doravirine Based on Phase III Results
Cochlear unveils hearing implants that work directly with Apple’s iPhone
U.S. Food and Drug Administration expands approval of Yervoy® (ipilimumab) to include pediatric patients 12 years and older with unresectable or metastatic melanoma
Antidepressant use in pregnant women linked to small increase in autism
Lilly and Nektar Therapeutics Announce Alliance
Samsung Bioepis launches Remicade biosmiliar
Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin
U.S. jury finds AbbVie liable for misrepresentation in AndroGel verdict
Merck & Co. Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study
Japanese Pharma Giant Astellas Sets Up Shop in Cambridge
Biogen raises 2017 forecast on Spinraza success
Eli Lilly Shakes Up Cancer R&D Strategy
Takeda, BioSurfaces Announce Research Program
Insulin resistance linked to lower bone density
CSL Behring Receives Orphan-Drug Exclusivity for Haegarda
AbbVie Receives CHMP Positive Opinion for Humira
Republicans’ push to roll back Obamacare faces crucial test
Samsung Bioepis launches U.S. sales of Remicade biosmiliar
Discovery Worldwide Names Rico Ricketson as Head of Client Services
How physical exercise prevents dementia
27 Phase III and 8 Phase II Alzheimer's drugs on track to launch in next 5 years
Merck and Pfizer collaborate with Corning
MAHF to hold its first Midwest seminar in September
Klick Health Expands Behavioral Science Team
Living healthily, learning more could cut dementia cases by a third
EU medicines agency recommends approval of Novartis leukemia drug Rydapt
Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval
Endo International Slashes 875 Jobs and Will Shutter Alabama Facilities
AstraZeneca CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo
Corning, Merck & Co. and Pfizer to Invest $4 Billion and Create 4,000 New Jobs in the U.S.